Cerebrolysin Concentrate — Drug Intelligence | 3 EU Trials

Filter these 3 trials by condition, phase, country and more.

3 Registered trials

2 Recruiting

1 Completed trials

2 Sponsors

2 Countries

Phase III

Phase II

Phase III/IV

Phase III: 1 Phase II: 1 Phase III/IV: 1

Indications tested

3 total

A confirmatory study to assess the efficacy of CEREBROLYSIN in post-acute ischemic stroke recovery Recruiting

2025-521350-41-01 Phase III 1 country Foundation For The Study Of Nanoneuroscience And Neuroregeneration
Efficacy and safety of Cerebrolysin for neurorecovery after moderate-severe traumatic brain injury Recruiting

2024-515591-12-00 Phase III/IV 1 country Foundation For The Study Of Nanoneuroscience And Neuroregeneration
Cerebrolysin in CADASIL Ended

2024-513828-42-00 Phase II 1 country Ever Neuro Pharma GmbH

Showing 1–3 of 3 trials